C12N 2740/16023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2740/16023 (Virus like particles [vlp]) appears on 124 US grants and 167 published applications in this corpus.
Search patents in C12N- Granted patents
- 124
- Published applications
- 167
- Assignees
- 113
- Inventors
- 358
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 11 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 2 |
| 2003 | 6 | 5 |
| 2004 | 2 | 4 |
| 2005 | 1 | 6 |
| 2006 | 2 | 4 |
| 2007 | 2 | 2 |
| 2008 | 1 | 5 |
| 2009 | 4 | 5 |
| 2010 | 3 | 4 |
| 2011 | 1 | 5 |
| 2012 | 1 | 4 |
| 2013 | 3 | 4 |
| 2014 | 3 | 1 |
| 2015 | 3 | 5 |
| 2016 | 1 | 2 |
| 2017 | 2 | 2 |
| 2018 | 3 | 6 |
| 2019 | 3 | 9 |
| 2020 | 4 | 11 |
| 2021 | 7 | 13 |
| 2022 | 8 | 17 |
| 2023 | 4 | 11 |
| 2024 | 9 | 17 |
| 2025 | 12 | 10 |
| 2026 | 2 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Virus-like particle16 Jun 2026US 12,655,388 B2Autolus Limited
- Compositions and methods for targeted delivery of CRISPR-Cas effector polypeptides and transgenes3 Mar 2026US 12,565,647 B2The Regents of the University of California
- Multivalent virus like particle vaccines23 Dec 2025US 12,502,425 B2Texas Tech University System
- Modified HIV-1 proviral vectors with enhanced dendritic cell transduction efficiencies comprising the JRFL envelope23 Dec 2025US 12,503,499 B2University of Massachusetts
- HIV-1 ENV fusion peptide immunogens and their use4 Nov 2025US 12,458,691 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Recombinant hiv env polypeptides and their use27 Aug 2026US 2026/0250331 A1International AIDS Vaccine Initiative
- Directed evolution of engineered virus-like particles (evlps)23 Jul 2026US 2026/0209747 A1President and Fellows of Harvard College
- Lipid particles with cofusogens and methods of producing and using the same16 Jul 2026US 2026/0199238 A1Sana Biotechnology, Inc.
- Engineered virus-like-particles for targeted capture of membrane proteins16 Jul 2026US 2026/0200991 A1
- Systems and methods for modifying a polynucleotide9 Jul 2026US 2026/0193679 A1Children's Medical Center Corporation
Most cited
By later US patents
- Retroviral packaging cell lines77US 5,591,624 AChiron Viagene, Inc. · 1997
- Expression of HIV polypeptides and production of virus-like particles73US 6,602,705 B1Chiron Corporation · 2003
- Recombinant retroviruses57US 5,716,613 AChiron Viagene, Inc. · 1998
- Recombinant retroviruses56US 5,716,826 AChiron Viagene, Inc. · 1998
- Chimeric Gag pseudovirions48US 6,099,847 AThe United States of America as represented by the Department of Health and Human Services · 2000